A blinded randomised placebo-controlled trial investigating the efficacy of morphine analgesia for procedural pain in infants: Trial protocol

Rebeccah Slater, Caroline Hartley, Fiona Moultrie, Eleri Adams, Ed Juszczak, Richard Rogers, Jane E Norman, Chetan Patel, Kayleigh Stanbury, Amy Hoskin, Gabrielle Green, Poppi Trial Team, Rebeccah Slater, Caroline Hartley, Fiona Moultrie, Eleri Adams, Ed Juszczak, Richard Rogers, Jane E Norman, Chetan Patel, Kayleigh Stanbury, Amy Hoskin, Gabrielle Green, Poppi Trial Team

Abstract

Infant pain has both immediate and long-term negative consequences, yet in clinical practice it is often undertreated. To date, few pain-relieving drugs have been tested in infants. Morphine is a potent analgesic that provides effective pain relief in adults, but there is inconclusive evidence for its effectiveness in infants. The purpose of this study is to establish whether oral morphine provides effective analgesia for procedural pain in infants. A blinded, placebo-controlled, parallel-group randomized, phase II, clinical trial will be undertaken to determine whether morphine sulphate administered orally prior to clinically-required retinopathy of prematurity (ROP) screening and heel lancing provides effective analgesia. 156 infants between 34 and 42 weeks' gestational age who require a clinical heel lance and ROP screening on the same test occasion will be included in the trial. Infants will be randomised to receive either a single dose of morphine sulphate (100 μg/kg) or placebo. Each infant will be monitored for 48 hours and safety data will be collected during the 24 hours following drug administration. The primary outcome will be the Premature Infant Pain Profile-revised (PIPP-R) score 30 seconds after ROP screening. The co-primary outcome will be the magnitude of nociceptive-specific brain activity evoked by a clinically-required heel lance. Infant clinical stability will be assessed by comparing the number of episodes of bradycardia, tachycardia, desaturation and apnoea, and changes in respiratory support requirements in the 24-hour periods before and after the clinical intervention. In addition, drug safety will be assessed by considering the occurrence of apnoeic and hypotensive episodes requiring intervention in the 24-hour period following drug administration. This study has been published as an Accepted Protocol Summary by The Lancet.

Keywords: Analgesia; Brain; EEG; Infant; Morphine; Pain; Retinopathy of Prematurity.

Conflict of interest statement

No competing interests were disclosed.

Figures

Figure 1.. Summary of the experimental protocol.
Figure 1.. Summary of the experimental protocol.
The clinical intervention is defined as the heel lance followed by the ROP screening. All timings are approximate and are in relation to the start of the clinical intervention (i.e. the heel lance).
Figure 2.. Trial flowchart.
Figure 2.. Trial flowchart.

References

    1. Hartley C, Moultrie F, Juszczak E, et al. : Protocol 15PRT/5747: A blinded randomised placebo-controlled trial investigating the efficacy of morphine analgesia for procedural pain in infants. Lancet. 2016.
    1. McNameea D, Jamesa A, Kleiner S: Protocol review at The Lancet. Lancet. 2008;372(9634):189–90. 10.1016/S0140-6736(08)61053-3
    1. The Editors of The Lancet: Protocol review at The Lancet: 1997– 2015. Lancet. 2015;386(10012):2456–2457. 10.1016/S0140-6736(15)01131-9
    1. Carbajal R, Rousset A, Danan C, et al. : Epidemiology and treatment of painful procedures in neonates in intensive care units. JAMA. 2008;300(1):60–70. 10.1001/jama.300.1.60
    1. McKechnie L, Levene M: Procedural pain guidelines for the newborn in the United Kingdom. J Perinatol. 2008;28(2):107–11. 10.1038/sj.jp.7211822
    1. Rodkey EN, Pillai Riddell R: The infancy of infant pain research: the experimental origins of infant pain denial. J Pain. 2013;14(4):338–50. 10.1016/j.jpain.2012.12.017
    1. Whyte S, Birrell G, Wyllie J: Premedication before intubation in UK neonatal units. Arch Dis Child Fetal Neonatal Ed. 2000;82(1):F38–41. 10.1136/fn.82.1.F38
    1. Sarkar S, Schumacher RE, Baumgart S, et al. : Are newborns receiving premedication before elective intubation? J Perinatol. 2006;26(5):286–9. 10.1038/sj.jp.7211499
    1. Green B: Special care for sick babies - choice or chance? The first BLISS baby report.2005.
    1. Anand KJ, International evidence-based group for neonatal pain : Consensus statement for the prevention and management of pain in the newborn. Arch Pediatr Adolesc Med. 2001;155(2):173–80. 10.1001/archpedi.155.2.173
    1. Royal College of Paediatrics and Child Health: Guideline for the screening and treatment of retinopathy of prematurity.2008.
    1. Belda S, Pallás CR, De la Cruz J, et al. : Screening for retinopathy of prematurity: is it painful? Biol Neonate. 2004;86(3):195–200. 10.1159/000079542
    1. Kleberg A, Warren I, Norman E, et al. : Lower stress responses after Newborn Individualized Developmental Care and Assessment Program care during eye screening examinations for retinopathy of prematurity: a randomized study. Pediatrics. 2008;121(5):e1267–78. 10.1542/peds.2006-2510
    1. Mitchell AJ, Green A, Jeffs DA, et al. : Physiologic effects of retinopathy of prematurity screening examinations. Adv Neonatal Care. 2011;11(4):291–7. 10.1097/ANC.0b013e318225a332
    1. Dempsey E, McCreery K: Local anaesthetic eye drops for prevention of pain in preterm infants undergoing screening for retinopathy of prematurity. Cochrane Database Syst Rev. 2011; (9):CD007645. 10.1002/14651858.CD007645.pub2
    1. Kandasamy Y, Smith R, Wright IM, et al. : Pain relief for premature infants during ophthalmology assessment. J AAPOS. 2011;15(3):276–80. 10.1016/j.jaapos.2011.03.009
    1. Sun X, Lemyre B, Barrowman N, et al. : Pain management during eye examinations for retinopathy of prematurity in preterm infants: a systematic review. Acta Paediatr. 2010;99(3):329–34. 10.1111/j.1651-2227.2009.01612.x
    1. Ahlers SJ, van Gulik L, van Dongen EP, et al. : Efficacy of an intravenous bolus of morphine 2.5 versus morphine 7.5 mg for procedural pain relief in postoperative cardiothoracic patients in the intensive care unit: a randomised double-blind controlled trial. Anaesth Intensive Care. 2012;40(3):417–26.
    1. Dyke MP, Kohan R, Evans S: Morphine increases synchronous ventilation in preterm infants. J Paediatr Child Health. 1995;31(3):176–9. 10.1111/j.1440-1754.1995.tb00780.x
    1. Anand KJ, Hall RW, Desai N, et al. : Effects of morphine analgesia in ventilated preterm neonates: primary outcomes from the NEOPAIN randomised trial. Lancet. 2004;363(9422):1673–82. 10.1016/S0140-6736(04)16251-X
    1. Anand KJ, Anderson BJ, Holford NH, et al. : Morphine pharmacokinetics and pharmacodynamics in preterm and term neonates: secondary results from the NEOPAIN trial. Br J Anaesth. 2008;101(5):680–9. 10.1093/bja/aen248
    1. Carbajal R, Lenclen R, Jugie M, et al. : Morphine does not provide adequate analgesia for acute procedural pain among preterm neonates. Pediatrics. 2005;115(6):1494–500. 10.1542/peds.2004-1425
    1. Bellù R, de Waal KA, Zanini R: Opioids for neonates receiving mechanical ventilation. Cochrane Database Syst Rev. 2008; (1):CD004212. 10.1002/14651858.CD004212.pub3
    1. Manjunatha C, Ibhanesebhor S, Rennix H, et al. : Pain control during retinopathy of prematurity screening: double-blind, randomised, placebo-controlled study. Infant. 2009;5(5):155–58.
    1. Stevens B, Johnston C, Petryshen P, et al. : Premature Infant Pain Profile: development and initial validation. Clin J Pain. 1996;12(1):13–22. 10.1097/00002508-199603000-00004
    1. Stevens BJ, Gibbins S, Yamada J, et al. : The premature infant pain profile-revised (PIPP-R): initial validation and feasibility. Clin J Pain. 2014;30(3):238–43. 10.1097/AJP.0b013e3182906aed
    1. Simonse E, Mulder PG, van Beek RH: Analgesic effect of breast milk versus sucrose for analgesia during heel lance in late preterm infants. Pediatrics. 2012;129(4):657–63. 10.1542/peds.2011-2173
    1. Campbell-Yeo ML, Johnston CC, Joseph KS, et al. : Cobedding and recovery time after heel lance in preterm twins: results of a randomized trial. Pediatrics. 2012;130(3):500–6. 10.1542/peds.2012-0010
    1. Taddio A, Shah V, Hancock R, et al. : Effectiveness of sucrose analgesia in newborns undergoing painful medical procedures. CMAJ. 2008;179(1):37–43. 10.1503/cmaj.071734
    1. Slater R, Worley A, Fabrizi L, et al. : Evoked potentials generated by noxious stimulation in the human infant brain. Eur J Pain. 2010;14(3):321–6. 10.1016/j.ejpain.2009.05.005
    1. Worley A, Fabrizi L, Boyd S, et al. : Multi-modal pain measurements in infants. J Neurosci Methods. 2012;205(2):252–7. 10.1016/j.jneumeth.2012.01.009
    1. Slater R, Cornelissen L, Fabrizi L, et al. : Oral sucrose as an analgesic drug for procedural pain in newborn infants: a randomised controlled trial. Lancet. 2010;376(9748):1225–32. 10.1016/S0140-6736(10)61303-7
    1. Slater R, Fabrizi L, Worley A, et al. : Premature infants display increased noxious-evoked neuronal activity in the brain compared to healthy age-matched term-born infants. Neuroimage. 2010;52(2):583–9. 10.1016/j.neuroimage.2010.04.253
    1. Vinall J, Miller SP, Bjornson BH, et al. : Invasive procedures in preterm children: brain and cognitive development at school age. Pediatrics. 2014;133(3):412–21. 10.1542/peds.2013-1863
    1. Taddio A, Crosdale B, Hogan ME, et al. : Safety of morphine in nonintubated infants in the neonatal intensive care unit. Clin J Pain. 2009;25(5):418–22. 10.1097/AJP.0b013e31819b7a3b
    1. Taddio A, Lee C, Yip A, et al. : Intravenous morphine and topical tetracaine for treatment of pain in [corrected] neonates undergoing central line placement. JAMA. 2006;295(7):793–800. 10.1001/jama.295.7.793
    1. Cornelissen L, Fabrizi L, Patten D, et al. : Postnatal temporal, spatial and modality tuning of nociceptive cutaneous flexion reflexes in human infants. PLoS One. 2013;8(10):e76470. 10.1371/journal.pone.0076470
    1. Lemyre B, Hogan DL, Gaboury I, et al. : How effective is tetracaine 4% gel, before a venipuncture, in reducing procedural pain in infants: a randomized double-blind placebo controlled trial. BMC Pediatr. 2007;7:7. 10.1186/1471-2431-7-7
    1. Gal P, Kissling GE, Young WO, et al. : Efficacy of sucrose to reduce pain in premature infants during eye examinations for retinopathy of prematurity. Ann Pharmacother. 2005;39(6):1029–33. 10.1345/aph.1E477
    1. Marsh VA, Young WO, Dunaway KK, et al. : Efficacy of topical anesthetics to reduce pain in premature infants during eye examinations for retinopathy of prematurity. Ann Pharmacother. 2005;39(5):829–33. 10.1345/aph.1E476
    1. Mehta M, Mansfield T, VanderVeen DK: Effect of topical anesthesia and age on pain scores during retinopathy of prematurity screening. J Perinatol. 2010;30(11):731–5. 10.1038/jp.2010.36
    1. Lorenz J, Beck H, Bromm B: Cognitive performance, mood and experimental pain before and during morphine-induced analgesia in patients with chronic non-malignant pain. Pain. 1997;73(3):369–75. 10.1016/S0304-3959(97)00123-1
    1. Truini A, Panuccio G, Galeotti F, et al. : Laser-evoked potentials as a tool for assessing the efficacy of antinociceptive drugs. Eur J Pain. 2010;14(2):222–5. 10.1016/j.ejpain.2009.05.001
    1. Attal N, Cruccu G, Haanpää M, et al. : EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol. 2006;13(11):1153–69. 10.1111/j.1468-1331.2006.01511.x
    1. Hollingshead J, Dühmke RM, Cornblath DR: Tramadol for neuropathic pain. Cochrane Database Syst Rev. 2006;3:CD003726. 10.1002/14651858.CD003726.pub3
    1. Norbury TA, MacGregor AJ, Urwin J, et al. : Heritability of responses to painful stimuli in women: a classical twin study. Brain. 2007;130(Pt 11):3041–9. 10.1093/brain/awm233
    1. Hochberg Y: A Sharper Bonferroni Procedure for Multiple Tests of Significance. Biometrika. 1988;75(4):800–802. 10.1093/biomet/75.4.800

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner